Cargando…

Histological comparison between preoperative and surgical specimens of non-small cell lung cancer for distinguishing between "squamous" and "non-squamous" cell carcinoma

BACKGROUND: Non-small cell lung cancers (NSCLCs) are frequently heterogeneous and in approximately 70% of cases, NSCLCs are diagnosed and staged by small biopsies or cytology rather than by examination of surgically resected specimens. Thus, in most patients, the diagnosis is established based on ex...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamagishi, Tomoko, Shimizu, Katsuhiko, Ochi, Nobuaki, Yamane, Hiromichi, Irei, Isao, Sadahira, Yoshito, Takigawa, Nagio, Oka, Mikio, Nakata, Masao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099154/ https://www.ncbi.nlm.nih.gov/pubmed/24885169 http://dx.doi.org/10.1186/1746-1596-9-103

Ejemplares similares

Epiphora in lung cancer patients receiving docetaxel: a case series
por: Yamagishi, Tomoko, et al.
Publicado: (2014)

“Engagement ring” image conveys regrettable outcome for aged patients with non‐small cell lung cancer
por: Yamane, Hiromichi, et al.
Publicado: (2018)

Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study
por: Yamane, Hiromichi, et al.
Publicado: (2015)

Docetaxel for non-small-cell lung cancer harboring the activated EGFR mutation with T790M at initial presentation
por: Yamane, Hiromichi, et al.
Publicado: (2013)

Acute necrotizing encephalopathy in an adult with influenza A infection
por: Ochi, Nobuaki, et al.
Publicado: (2018)

Erythema as a Visual Surrogate Marker of Glucagonoma
por: Ochi, Nobuaki, et al.
Publicado: (2018)

High Uptake of FDG Along a Biliary Stent
por: Nagasaki, Yasunari, et al.
Publicado: (2016)

Cisplatin-induced hyponatremia in malignancy: comparison between brand-name and generic formulation
por: Ochi, Nobuaki, et al.
Publicado: (2014)

Obstructive jaundice caused by intraductal metastasis of lung adenocarcinoma
por: Ochi, Nobuaki, et al.
Publicado: (2014)

Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17
por: Yamane, Hiromichi, et al.
Publicado: (2018)

Herpetic esophagitis following bendamustine-containing regimen
por: Yamane, Hiromichi, et al.
Publicado: (2016)

Patients with osteosarcoma and soft tissue sarcoma might become “cancer refugees” in some Japanese regional cities
por: Yamane, Hiromichi, et al.
Publicado: (2018)

Chest computed‐tomography 1 day before the diagnosis of coronavirus disease 2019
por: Yamane, Hiromichi, et al.
Publicado: (2023)

Ceftriaxone-associated pancreatitis captured on serial computed tomography scans
por: Nakagawa, Nozomu, et al.
Publicado: (2017)

Clinical Features of Patients With Hematological Malignancies Treated at the Palliative Care Unit
por: Yamane, Hiromichi, et al.
Publicado: (2023)

Successful palliation for an aged patient with primary pericardial mesothelioma
por: Isoda, Ryutaro, et al.
Publicado: (2015)

Wandering consolidation
por: Kawahara, Tatsuyuki, et al.
Publicado: (2019)

Do Elderly Lung Cancer Patients Aged ≥75 Years Benefit from Immune Checkpoint Inhibitors?
por: Takigawa, Nagio, et al.
Publicado: (2020)

Lung cancer metastasis to the pancreas mimicking autoimmune pancreatitis
por: Ichiyama, Naruhiko, et al.
Publicado: (2021)

IgA Vasculitis in a Lung Cancer Patient During Chemoradiotherapy
por: Taoka, Masataka, et al.
Publicado: (2021)

Oligoprogression in Non-Small Cell Lung Cancer
por: Harada, Daijiro, et al.
Publicado: (2021)

Twenty-Seven Years of Phase III Trials for Patients with Extensive Disease Small-Cell Lung Cancer: Disappointing Results
por: Oze, Isao, et al.
Publicado: (2009)

Herpes zoster in lung cancer patients treated with PD-1/PD-L1 inhibitors
por: Taoka, Masataka, et al.
Publicado: (2022)

The Role of STAT3 in Non-Small Cell Lung Cancer
por: Harada, Daijiro, et al.
Publicado: (2014)

Treatment-Related Death in Patients with Small-Cell Lung Cancer in Phase III Trials over the Last Two Decades
por: Ochi, Nobuaki, et al.
Publicado: (2012)

Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
por: Yoshida, Masakazu, et al.
Publicado: (2018)

Eight potential biomarkers for distinguishing between lung adenocarcinoma and squamous cell carcinoma
por: Xiao, Jian, et al.
Publicado: (2017)

Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma
por: Shimizu, Katsuhiko, et al.
Publicado: (2014)

Descending necrotizing mediastinitis in a healthy young adult
por: Ochi, Nobuaki, et al.
Publicado: (2018)

Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer
por: Shimizu, Katsuhiko, et al.
Publicado: (2019)

Trefoil Factor 3 as a Novel Biomarker to Distinguish Between Adenocarcinoma and Squamous Cell Carcinoma
por: Wang, Xiao-Nan, et al.
Publicado: (2015)

Desmoglein 3 and Keratin 14 for Distinguishing Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma
por: Dong, Yanting, et al.
Publicado: (2020)

SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
por: Fukazawa, Takuya, et al.
Publicado: (2016)

Comprehensive Analysis and Identification of Key Driver Genes for Distinguishing Between Esophageal Adenocarcinoma and Squamous Cell Carcinoma
por: Wang, Feng, et al.
Publicado: (2021)

Mutant Screen Distinguishes between Residues Necessary for Light-Signal Perception and Signal Transfer by Phytochrome B
por: Oka, Yoshito, et al.
Publicado: (2008)

Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers
por: Tian, Yijun, et al.
Publicado: (2017)

Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma
por: Yokota, Etsuko, et al.
Publicado: (2017)

Lung adenocarcinoma and squamous cell carcinoma difficult for immunohistochemical diagnosis can be distinguished by lipid profile
por: Yamashita, Takashi, et al.
Publicado: (2023)

Neuroendocrine differentiation distinguishes basaloid variant of lung squamous cell carcinoma
por: Keyhanian, Kianoosh, et al.
Publicado: (2022)

Distinguish between typical non-Hermitian quantum systems by entropy dynamics
por: Zheng, Chao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_be8sg4s2j04hkui5hosbd2pc42